CSE Bulletin: Consolidation - HAVN Life Sciences Inc. (HAVN)

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Toronto, Ontario--(Newsfile Corp. - Le 2 août/August 2022) - HAVN Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 5,109,665 common shares.

The name and symbol will not change.

Please note that all open orders will be cancelled at the close of business on August 2, 2022. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

HAVN Life Sciences Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour trente (30) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 5 109 665 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que tous les ordres ouverts seront annulés à la fermeture des bureaux le 2 août 2022. Il est rappelé aux concessionnaires de saisir à nouveau leurs ordres en tenant compte du regroupement d'actions.

Trading on a Consolidated Basis/Négociation sur une base consolidée:

Le 3 août/August 2022

Record Date/Date d’enregistrement:

Le 4 août/August 2022

Symbol/Symbole:

HAVN

NEW/NOUVEAU CUSIP:

419621 30 5

NEW/NOUVEAU ISIN:

CA 419621 30 5 8

Old/Vieux CUSIP & ISIN:

419621107/CA4196211078

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected].

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à: [email protected].

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).